ArticleCureus2025
Health-Related Quality of Life After Laparoscopic Nissen Fundoplication: A Long-Term Single-Center Cohort Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
objectivesGastro-oesophageal reflux disease (GERD) significantly impairs quality of life, particularly in patients with persistent symptoms despite optimal medical therapy. Laparoscopic Nissen fundoplication (LNF) is considered the gold-standard surgical treatment for well-characterised, refractory GERD. This study aimed to retrospectively evaluate long-term health-related quality of life (HRQoL), patient satisfaction, and proton pump inhibitor (PPI) use following LNF in a single-centre cohort.
methodsAll consecutive patients undergoing LNF at our institution between January 2009 and December 2019 were retrospectively reviewed. Demographic data, medication use, reoperations, and satisfaction were collected. Symptom burden was assessed using an adapted version of the validated GERD-HRQL questionnaire, administered by a structured telephone interview. Pre- and postoperative scores were compared using the Wilcoxon signed-rank test, with significance set at p < 0.05.
resultsSixty-eight patients were included (79.4% female, median age 66 years). Median follow-up was 5.5 years. Postoperative discontinuation of PPIs occurred in 53.7% of patients; those who continued therapy were mostly receiving concomitant ulcerogenic medication. Satisfaction with surgical outcome was reported by 84.6% of respondents. GERD-HRQL scores, assessed with the adapted instrument, improved significantly across most domains, including heartburn, regurgitation, and symptom-related sleep and dietary interference (all p < 0.001). Dysphagia showed a non-significant trend towards improvement (p = 0.084). Reoperation was required in two patients (2.9%), and no procedure-related mortality occurred.
conclusionLNF offers durable symptom relief, improved HRQoL, and high long-term satisfaction, with low reoperation rates. Persistent PPI use and the non-significant trend in dysphagia highlight the importance of realistic preoperative counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.